Structural and Immunocytochemical Differentiation of Neurons in Prenatal and Postnatal Human Prefrontal Cortex
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background and Aims: In the prenatal and postnatal period, the human cortex undergoes different phases of development. The question therefore was, which phases of growth characterize pyramidal and nonpyramidal neurons in the human prefrontal cortex. Results and Conclusions: The major neuronal outgrowth occurs mainly in the first 2 postnatal years, both for pyramidal and nonpyramidal cells. The mature level of outgrowth is reached at about 3–4 years. The neurochemical specification, however, is then still not at the mature level. The mature distribution of neuropeptide Y, calbindin and parvalbumin immunoreactive nonpyramidal neurons is observed in early puberty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeFelipe, J. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)10013-8 · Cited by 550
Age-related Volumetric Changes of Brain Gray and White Matter in Healthy Infants and Children
Matsuzawa, J. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.4.335 · Cited by 315
Kostovic, I., & Goldman‐Rakic, P. S. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902190405 · Cited by 260
Chapter 9 Neuronal development in human prefrontal cortex in prenatal and postnatal stages
Mrzljak, L., Uylings, H. B. M., Van Eden, G. G., & Judáš, M. (1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62681-3 · Cited by 247
Self-citationAnderson, S. A., Classey, J. D., Condé, F., Lund, J. S., & Lewis, D. A. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00051-j · Cited by 245
Alc�ntara, S., Ferrer, I., & Soriano, E. (1993) · Anatomy and Embryology · doi:10.1007/bf00191452 · Cited by 174
Kostović, I. (1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62682-5 · Cited by 127
Koenderink, M. J. T., Uylings, H. B. M., & Mrzljak, L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90387-5 · Cited by 98
Self-citationKalsbeek, A., De Bruin, J. P. C., Feenstra, M. G. P., & Uylings, H. B. M. (1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62684-9 · Cited by 43
Self-citation
Cited by
Assembly of functionally integrated human forebrain spheroids
Birey, F., Andersen, J., Makinson, C. D., Islam, S., Wei, W., Huber, N., Fan, H. C., Metzler, K. R. C., Panagiotakos, G., Thom, N., et al. (2017) · Nature · doi:10.1038/nature22330 · Cited by 1,365
Trujillo, C. A., Gao, R., Negraes, P. D., Gu, J., Buchanan, J., Preissl, S., Wang, A., Wu, W., Haddad, G. G., Chaim, I. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.08.002 · Cited by 974
“Notably, GABAergic neurons were mainly restricted to 6- to 10-month organoids, reaching around 10%–15% of the total neural population after 10 months, consistent with its presence later in the in vivo development (Uylings et al., 2002).”
BackgroundRajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301234 · Cited by 430
“…of nonpyramidal GABAergic neurons that can be identified with antibodies specific to calcium binding proteins: calbindin-D28k (CB), parvalbumin (PV), and calretinin (Beasley et al, 2002; Conde et al, 1994; Cotter et al, 2002a; DeFelipe, 1997; Uylings et al, 2002; Zaitsev et al, 2005).”
BackgroundPCP: from pharmacology to modelling schizophrenia
Morris, B. J., Cochran, S. M., & Pratt, J. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.008 · Cited by 308
Petanjek, Z., Judas, M., Kostovic, I., & Uylings, H. B. M. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm124 · Cited by 273
Self-citation
Metadata
- Authors
- Uylings, H. B. M., Delalle, I., Petanjek, Z., & Koenderink, M. J. T.
- Venue
- Neuroembryology and Aging
- Publisher
- S. Karger AG
- Published
- 2002
- Volume
- 1
- Issue
- 4
- Pages
- 176-186
- ISSN
- 1661-3406 (ISSN-L)
- 1661-3414
- OpenAlex
- W2035453793
- Cited by
- 17
- References
- 9
- FWCI
- 0.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.